M Pharmaceutical Inc. | Income Statement
Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
-
-
642.80
Cost of Goods Sold (COGS) incl. D&A
121.10
-
-
1.50
1,640.60
Gross Income
121.10
-
-
1.50
997.80
SG&A Expense
784.20
813.70
3,859.60
2,410.80
2,700.30
EBIT
905.30
813.80
-
2,412.20
3,698.10
Unusual Expense
9,773.20
242.30
177.30
720.30
3,995.90
Non Operating Income/Expense
44.40
269.30
205.10
-
351.10
Interest Expense
27.40
47.30
90.50
376.60
533.30
Pretax Income
10,661.60
349.40
3,977.90
2,068.50
8,578.40
Consolidated Net Income
10,661.60
349.40
3,977.90
2,068.50
8,578.40
Net Income
10,661.60
349.40
3,977.90
2,068.50
8,578.40
Net Income After Extraordinaries
10,661.60
349.40
3,977.90
2,068.50
8,578.40
Net Income Available to Common
10,661.60
349.40
3,977.90
2,068.50
8,578.40
EPS (Basic)
89.00
1.00
1.80
0.30
0.38
Basic Shares Outstanding
119.70
546.20
2,231.20
6,188.90
22,654.70
EPS (Diluted)
89.08
0.64
1.78
0.33
0.38
Diluted Shares Outstanding
119.70
546.20
2,231.20
6,188.90
22,654.70
EBITDA
845.30
813.80
3,859.60
2,410.80
3,255.60
Non-Operating Interest Income
0.00
-
-
-
-
About M Pharmaceutical
View Profile
